Online Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Remeron Fails to Help Treat Breathing Problems from COPD, Lung Disease: StudyResearchers warn that antidepressants like Remeron should not be prescribed off-label for breathlessness, as they may cause additional complications. September 17, 2024 Martha Garcia Add Your CommentsA new study indicates that antidepressants like Remeron do not help reduce symptoms of breathlessness associated with chronic obstructive pulmonary disease (COPD) or interstitial lung disease, and may actually cause additional side effects, which could even lead to death.In a report published in the medical journal Lancet Respiratory Medicine on September 9, researchers from King’s College London warn against the use of Remeron and similar antidepressants to treat breathlessness, recommending that doctors not prescribe the drugs to patients for this “off-label” indication.Remeron, also known by its generic name mirtazapine, is a common antidepressant prescribed for severe depressive disorder and anxiety. However, it is often prescribed off-label to patients with interstitial lung disease and COPD to help with symptoms of breathlessness.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONIn the study, researchers led by Dr. Irene J. Higginson conducted a double-blind randomized trial at 16 centers in seven countries, including Australia, Germany, Ireland, Italy, New Zealand, Poland and the UK, from 2021 to 2023The study included 225 adults with COPD, interstitial lung disease or both conditions, who also experienced serious symptoms of breathlessness. Patients were given a placebo or Remeron for 56 days. The Remeron dose began at 15 mg and was increased to a maximum of 45 mg per day throughout the treatment.According to the data, by day 56 the patients in both groups were no longer experiencing any improvement in breathlessness. However, there were more side effects experienced in the Remeron group.A total of 64% of patients in the Remeron group had side effects, compared to 40% in the placebo group. Six Remeron participants suffered 11 serious side effects, compared to eight side effects among seven participants in the placebo group.Moreover, by day 56, three people in the Remeron group had died, compared to only two in the placebo group. By six months, seven people in the Remeron group died.As a result of the findings, researchers highlighted the importance of medical providers being cautious when prescribing drugs off-label, since research often hasnโt been conducted to evaluate the safety or efficacy ofย those specific uses.Antidepressants Can Lead to Additional DifficultiesAlthough antidepressants are widely used, the drugs do come with a number of known risks, especially among certain groups of patients.Among older patients, prior research has found that taking antidepressants can increase a personโs risk of experiencing delirium.ย This can also increase the likelihood that an older person might suffer a fall, resulting in life-changing injuries.Another study conducted by researchers from the University of Michigan linked taking Remeron to an increased risk of getting infections like clostridium difficile (C. diff), which is a serious infection that causes diarrhea and inflammation in the colon. It can be life-threatening.Unnecessary use of prescription medications that have not been shown to be effective in treating an underlying condition can also increase the risk of drug interactions, or delay the administration of more effective therapies.โBased on existing best evidence, early identification and non-pharmacological approaches should be first-line treatment for the symptoms of breathlessness,โ Higginson said. โThese include an appropriately personalized approach to symptom management, with a continuum of approaches including pulmonary rehabilitation in earlier stages, interventions to improve peripheral muscle strength, and, when patients have more advanced disease, breathlessness support services that combine respiratory and palliative approaches, as all have been shown to be effective in randomized controlled trials and systematic reviews.โ Written by: Martha GarciaHealth & Medical Research WriterMartha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Antidepressant, Antidepressant Medication, Antidepressants, Breathlessness, COPD, Interstitial Lung Disease, Lung Disease, Remeron Image Credit: ABO PHOTOGRAPHYMore Lawsuit Stories Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers November 13, 2026 Port Catheter Lawsuit Links SmartPort to Infections, Sepsis November 13, 2026 Online Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending November 13, 2026 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026) Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Online Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending November 13, 2026
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)